ARCHIVES

Agencies Plan Better Reporting Of Adverse Events In Trials.

This article is from The Cancer Letter archive.

Vol. 26 No. 05 | February 4, 2000

Download PDF Visit The Full Archive

Related Articles

UICC Merit Award Winners Announced

September 19, 1986

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

OCC to Take Over CIS Oct; Cost Sharing “Is Dead”

July 15, 1988